Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-03

Clinical Trial Update: Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.

View source ↗

Summary

A prospective multicenter trial completed to evaluate the relationship between serum ustekinumab levels and clinical, biological, and endoscopic remission in Cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Hospital Universitario La Paz | Conditions: Ustekinumab Serum Levels in Patients With Crohn´s Disease | Status: COMPLETED